DGX
29
2
PSX
27
2
GT
47
4
PAYX
45
6
M
48
2
AEP
43
-4
NWSA
75
8
SBUX
36
5
SLB
45
4
HBI
56
3
D
35
2
HES
53
4
MSFT
58
4
ADI
59
2
ETR
65
4
ADSK
63
2
PPL
47
3
VTR
46
3
THC
53
3
NUE
41
2
DGX
29
2
PSX
27
2
GT
47
4
PAYX
45
6
M
48
2
AEP
43
-4
NWSA
75
8
SBUX
36
5
SLB
45
4
HBI
56
3
D
35
2
HES
53
4
MSFT
58
4
ADI
59
2
ETR
65
4
ADSK
63
2
PPL
47
3
VTR
46
3
THC
53
3
NUE
41
2
Financhill
Back

Vipshop Holdings 10K Form

Buy
51

VIPS
Vipshop Holdings

Last Price:
$13.65
Seasonality Move:
25.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VIPS News And Ratings

See the #1 stock for the next 7 days that we like better than VIPS

VIPS Financial Statistics

Sales & Book Value

Annual Sales: $16B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $10.45
Price / Book: 1.3

Profitability

EPS (TTM): 2.08750
Net Income (TTM): $1.1B
Gross Margin: $3.6B
Return on Equity: 21.46%
Return on Assets: 12%

Vipshop Holdings Earnings Forecast

Key Vipshop Holdings Financial Ratios

  • The Gross Profit Margin over the past 15 years for VIPS is 22.79%.
  • The Selling, General & Administrative Expenses for VIPS have been equal to 6.55% of Gross Profit Margin.
  • The Research & Development expenses have been 1.69% of Revenue.
  • The Interest Expense is 0.28% of Operating Income.
  • The Net Earning history of VIPS is 7.19% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 9 years.

Vipshop Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Broadline Retail
Sector: Consumer Discretionary
Current Symbol: VIPS
CUSIP: 92763W
Website: vip.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 1.21
Quick Ratio: 1.01

Price-to-Earnings

Trailing P/E Ratio: 6.69
Forward P/E Ratio: 5.82

VIPS Technical Analysis vs Fundamental Analysis

Buy
51
Vipshop Holdings (VIPS) is a Buy

Is Vipshop Holdings a Buy or a Sell?

  • Vipshop Holdings stock is rated a Buy
    The current Vipshop Holdings [VIPS] share price is $13.63. The Score for VIPS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.